ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway

出版年份 2019 全文链接

标题

作者

关键词

Colorectal cancer, Cervical cancer, H3K4 methylation, Chemotherapy sensitivity

出版物

Volume 454, Issue -, Pages 179-190

出版商

Elsevier BV

发表日期

2019-04-10

DOI

10.1016/j.canlet.2019.03.052

联系作者

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started